Advertisement

Topics

NIH backs study of CivaTech's targeted radiation device

06:36 EDT 22 Sep 2016 | SmartBrief

The NIH has awarded Durham, N.C.-based CivaTech Oncology a $2.3 million grant to conduct a two-year study evaluating its Civa -More

Original Article: NIH backs study of CivaTech's targeted radiation device

NEXT ARTICLE

More From BioPortfolio on "NIH backs study of CivaTech's targeted radiation device"

Quick Search
Advertisement
 

Relevant Topic

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...